Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 137

1.

Timing of onset affects arthritis presentation pattern in antisyntethase syndrome.

González-Gay MA, Montecucco C, Selva-O'Callaghan A, Trallero-Araguas E, Molberg O, Andersson H, Rojas-Serrano J, Perez-Roman DI, Bauhammer J, Fiehn C, Neri R, Barsotti S, Lorenz HM, Doria A, Ghirardello A, Iannone F, Giannini M, Franceschini F, Cavazzana I, Triantafyllias K, Benucci M, Infantino M, Manfredi M, Conti F, Schwarting A, Sebastiani G, Iuliano A, Emmi G, Silvestri E, Govoni M, Scirè CA, Furini F, Lopez-Longo FJ, Martínez-Barrio J, Sebastiani M, Manfredi A, Bachiller-Corral J, Sifuentes Giraldo WA, Cimmino MA, Cosso C, Belotti Masserini A, Cagnotto G, Codullo V, Romano M, Paolazzi G, Pellerito R, Saketkoo LA, Ortego-Centeno N, Quartuccio L, Batticciotto A, Bartoloni Bocci E, Gerli R, Specker C, Bravi E, Selmi C, Parisi S, Salaffi F, Meloni F, Marchioni E, Pesci A, Dei G, Confalonieri M, Tomietto P, Nuno L, Bonella F, Pipitone N, Mera-Valera A, Perez-Gomez N, Gerzeli S, Lopez-Mejias R, Matos-Costa CJ, Pereira da Silva JA, Cifrian J, Alpini C, Olivieri I, Blázquez Cañamero MÁ, Rodriguez Cambrón AB, Castañeda S, Cavagna L; AENEAS (American and European NEtwork of Antisynthetase Syndrome) collaborative group.

Clin Exp Rheumatol. 2017 Jul 26. [Epub ahead of print]

PMID:
28770709
2.

Renal tubular epithelial cell-derived BAFF expression mediates kidney damage and correlates with activity of proliferative lupus nephritis in mouse and men.

Schwarting A, Relle M, Meineck M, Föhr B, Triantafyllias K, Weinmann A, Roth W, Weinmann-Menke J.

Lupus. 2017 Jan 1:961203317717083. doi: 10.1177/0961203317717083. [Epub ahead of print]

PMID:
28659046
3.

[Hepatic manifestation of a macrophage activation syndrome (MAS)].

Nagel M, Schwarting A, Straub BK, Galle PR, Zimmermann T.

Z Gastroenterol. 2017 May;55(5):473-478. doi: 10.1055/s-0043-106445. Epub 2017 Apr 4. German.

PMID:
28376538
4.

[Autoimmune rheumatic diseases: from symptom to diagnosis].

Fasola F, Schwarting A.

MMW Fortschr Med. 2017 Apr;159(6):44-51. doi: 10.1007/s15006-017-9039-1. German. No abstract available.

PMID:
28374405
5.

Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study.

Bartoloni E, Gonzalez-Gay MA, Scirè C, Castaneda S, Gerli R, Lopez-Longo FJ, Martinez-Barrio J, Govoni M, Furini F, Pina T, Iannone F, Giannini M, Nuño L, Quartuccio L, Ortego-Centeno N, Alunno A, Specker C, Montecucco C, Triantafyllias K, Balduzzi S, Sifuentes-Giraldo WA, Paolazzi G, Bravi E, Schwarting A, Pellerito R, Russo A, Selmi C, Saketkoo LA, Fusaro E, Parisi S, Pipitone N, Franceschini F, Cavazzana I, Neri R, Barsotti S, Codullo V, Cavagna L.

Autoimmun Rev. 2017 Mar;16(3):253-257. doi: 10.1016/j.autrev.2017.01.008. Epub 2017 Jan 29. Review.

PMID:
28147261
6.

Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty-Two-Week Randomized, Double-Blind, Placebo-Controlled Study.

Stohl W, Schwarting A, Okada M, Scheinberg M, Doria A, Hammer AE, Kleoudis C, Groark J, Bass D, Fox NL, Roth D, Gordon D.

Arthritis Rheumatol. 2017 May;69(5):1016-1027. doi: 10.1002/art.40049. Epub 2017 Apr 7.

7.

[Evidence-based recommendations for diagnostics and treatment of gouty arthritis in the specialist sector : S2e guidelines of the German Society of Rheumatology in cooperation with the AWMF].

Kiltz U, Alten R, Fleck M, Krüger K, Manger B, Müller-Ladner U, Nüsslein H, Reuss-Borst M, Schwarting A, Schulze-Koops H, Tausche AK, Braun J.

Z Rheumatol. 2017 Mar;76(2):118-124. doi: 10.1007/s00393-016-0249-1. Review. German.

PMID:
28078432
8.

First Real-World Insights into Belimumab Use and Outcomes in Routine Clinical Care of Systemic Lupus Erythematosus in Germany: Results from the OBSErve Germany Study.

Schwarting A, Schroeder JO, Alexander T, Schmalzing M, Fiehn C, Specker C, Perna A, Cholmakow-Bodechtel C, Koscielny VB, Carnarius H.

Rheumatol Ther. 2016 Dec;3(2):271-290. Epub 2016 Nov 1.

9.

Impact of concomitant medication use on belimumab efficacy and safety in patients with systemic lupus erythematosus.

Schwarting A, Dooley MA, Roth DA, Edwards L, Thompson A, Wilson B.

Lupus. 2016 Dec;25(14):1587-1596. Epub 2016 Aug 3.

10.

Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials.

Clowse ME, Wallace DJ, Furie RA, Petri MA, Pike MC, Leszczyński P, Neuwelt CM, Hobbs K, Keiserman M, Duca L, Kalunian KC, Galateanu C, Bongardt S, Stach C, Beaudot C, Kilgallen B, Gordon C; EMBODY Investigator Group.

Arthritis Rheumatol. 2017 Feb;69(2):362-375. doi: 10.1002/art.39856.

11.

Genetics and pathophysiology of granulomatosis with polyangiitis (GPA) and its main autoantigen proteinase 3.

Relle M, Föhr B, Fasola F, Schwarting A.

Mol Cell Probes. 2016 Dec;30(6):366-373. doi: 10.1016/j.mcp.2016.08.009. Epub 2016 Aug 21. Review.

PMID:
27559009
12.

[The regional network ADAPTHERA : Rheumatology care through coordinated cooperation: comprehensive, trans-sectoral, covering all health insurance. Initial results].

Schwarting A, Pfeiff B, Amberger C, Pick D, Hesse M, Jendro M, Engels J, Böttger A, Kuhn C, Majdandzic J, Ziese W, Stadelmann ML, Kessler FW, Dinges H, Ultes-Kaiser S, Droste U, Schmalhofer M, Hazenbiller A, Rector M, Weinmann-Menke J, Triantafyllias K, Becker M, Ataian M, Lablans M, Ueckert F, Panholzer T, Blettner M.

Z Rheumatol. 2016 Dec;75(10):999-1005. German.

PMID:
27535273
13.

[Full version of the S2e guidelines on gouty arthritis : Evidence-based guidelines of the German Society of Rheumatology (DGRh)].

Kiltz U, Alten R, Fleck M, Krüger K, Manger B, Müller-Ladner U, Nüßlein H, Reuss-Borst M, Schwarting A, Schulze-Koops H, Tausche A, Braun J.

Z Rheumatol. 2016 Aug;75 Suppl 2:11-60. doi: 10.1007/s00393-016-0147-6. Review. German. No abstract available.

PMID:
27481119
14.

The count of tender rather than swollen joints correlates with aortic stiffness in patients with rheumatoid arthritis.

Triantafyllias K, De Blasi M, Hoffmann I, Thomaidis T, Drees P, Schwarting A.

Springerplus. 2016 Apr 11;5:428. doi: 10.1186/s40064-016-2066-z. eCollection 2016.

15.

Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group.

Cavagna L, Nuño L, Scirè CA, Govoni M, Longo FJ, Franceschini F, Neri R, Castañeda S, Sifuentes Giraldo WA, Caporali R, Iannone F, Fusaro E, Paolazzi G, Pellerito R, Schwarting A, Saketkoo LA, Ortego-Centeno N, Quartuccio L, Bartoloni E, Specker C, Pina Murcia T, La Corte R, Furini F, Foschi V, Bachiller Corral J, Airò P, Cavazzana I, Martínez-Barrio J, Hinojosa M, Giannini M, Barsotti S, Menke J, Triantafyllias K, Vitetta R, Russo A, Bogliolo L, Bajocchi G, Bravi E, Barausse G, Bortolotti R, Selmi C, Parisi S, Salaffi F, Montecucco C, González-Gay MA; AENEAS (American and European NEtwork of Antisynthetase Syndrome) Collaborative Group.

Clin Rev Allergy Immunol. 2017 Feb;52(1):71-80. doi: 10.1007/s12016-016-8528-9. Review.

PMID:
26782036
16.

Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome: Results From an International Retrospective Multicenter Study.

Cavagna L, Nuño L, Scirè CA, Govoni M, Longo FJ, Franceschini F, Neri R, Castañeda S, Sifuentes Giraldo WA, Caporali R, Iannone F, Fusaro E, Paolazzi G, Pellerito R, Schwarting A, Saketkoo LA, Ortego-Centeno N, Quartuccio L, Bartoloni E, Specker C, Murcia TP, La Corte R, Furini F, Foschi V, Corral JB, Airò P, Cavazzana I, Martínez-Barrio J, Hinojosa M, Giannini M, Barsotti S, Menke J, Triantafyllias K, Vitetta R, Russo A, Bajocchi G, Bravi E, Barausse G, Bortolotti R, Selmi C, Parisi S, Montecucco C, González-Gay MA; AENEAS (American, European NEtwork of Antisynthetase Syndrome) collaborative group.

Medicine (Baltimore). 2015 Aug;94(32):e1144. doi: 10.1097/MD.0000000000001144.

17.

Impact of switching from mycophenolate mofetil to enteric-coated mycophenolate sodium on gastrointestinal side effects in patients with autoimmune disease: a Phase III, open-label, single-arm, multicenter study.

Manger B, Hiepe F, Schneider M, Worm M, Wimmer P, Paulus EM, Schwarting A.

Clin Exp Gastroenterol. 2015 Jul 21;8:205-13. doi: 10.2147/CEG.S81922. eCollection 2015.

18.

Genetics and novel aspects of therapies in systemic lupus erythematosus.

Relle M, Weinmann-Menke J, Scorletti E, Cavagna L, Schwarting A.

Autoimmun Rev. 2015 Nov;14(11):1005-18. doi: 10.1016/j.autrev.2015.07.003. Epub 2015 Jul 9. Review.

PMID:
26164648
19.

Epigenetic Aspects of Systemic Lupus Erythematosus.

Relle M, Foehr B, Schwarting A.

Rheumatol Ther. 2015 Jun;2(1):33-46. Epub 2015 Jun 16. Review.

20.

Correlation between cell free DNA levels and medical evaluation of disease progression in systemic lupus erythematosus patients.

Tug S, Helmig S, Menke J, Zahn D, Kubiak T, Schwarting A, Simon P.

Cell Immunol. 2014 Nov-Dec;292(1-2):32-9. doi: 10.1016/j.cellimm.2014.08.002. Epub 2014 Aug 20.

PMID:
25243646

Supplemental Content

Loading ...
Support Center